9ZP-30295-71899
3 vaccinations
4 coded responses
7 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 024 / MA
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Moderna
-
2021-02-27
Dose 2 — Moderna
-
2021-03-01
Registered in v-safe
-
2021-03-04
Survey response — days 1–6 daily, dose 2MedDRA: Herpes zoster — Feeling: Poor · Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: ShinglesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-04
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Herpes zoster — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: ShinglesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — day 7, dose 2MedDRA: Herpes zoster — Feeling: Poor · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: ShinglesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
- 2021-03-20
-
2021-11-24
Dose 3 — Moderna
-
2022-01-23
Call successfulParticipant prefers to complete VAERS report online
- 2022-02-27
-
2022-05-26
Survey response — 6 months, dose 3MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Delivered healthy baby vaginallyMedDRA releases: 2024-11 · check-in free text available
-
2022-05-26
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-05-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Moderna | |
| 2 | 2021-02-27 | Moderna | |
| 3 | 2021-11-24 | Moderna | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Shingles
Systemic reaction (other): Shingles
Release 5 — day 7, dose 2
Systemic reaction (other): Shingles
Release 11 — 6 months, dose 3
Symptoms: Delivered healthy baby vaginally
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SRO | Herpes zoster | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release